Second International Congress Drug Therapy in HIV Infection 18-22 November 1994 Glasgow, UK

CLINICAL RESEARCH, PROPHYLAXIS, THERAPY, AND CARE FOR HIV DISEASE IN RESOURCE-POOR COUNTRIES

Kevin M. De Cock
London School of Hygiene and Tropical Medicine

Int Cong Drug Therapy HIV 1994 Nov 18-22;2:Abstract No. 8.1
AIDS 1994, Vol. 8 (Suppl. 4);S7

Approximately 90% of global HIV infections have occurred in citizens of resource-poor countries; over 12.5 million persons are living with HIV in non-industrialized countries. Emphasis on prevention in the early stages of the HIV/AIDS epidemic in resource-poor areas is now tempered by realization of the need to address appropriate, affordable levels of care. Research is required for better understanding of the natural history and spectrum of disease of HIV/AIDS in resource-poor countries, including the nature, timing and frequency of the major opportunistic diseases.

Gynaecologic and paediatric aspects of HIV disease have been particularly neglected. The efficacy of prophylactic therapy against specific diseases such as tuberculosis and toxoplasmosis needs to studied, as well as the feasibility of their implementation. Therapy for specific conditions needs to be evaluated, and drug requirements determined. Better definition of overall needs for care of persons with HIV/AIDS, including nursing, psychosocial support, and terminal care is required. Attempts are required to limit the widening gap between interventions available for HIV-infected persons in different parts of the world.

Presenting author: Kevin M. De Cock

1994-11-18
8.1

Originally published in AIDS Volume 8, Supplement 4 and hosted with permission of the publisher Lippincott Williams & Wilkins, 250 Waterloo Road, London, SE1 8RD, UK. Tel: +44 (0)20 7981 0700 Fax: +44 (0) 7981 0701

Copyright © 1994 - Lippincott Williams & Wilkins. All rights reserved. All abstracts from the 2nd International Congress Drug Therapy in HIV Infection, appearing on the AEGiS web site, are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, or otherwise published without the prior written permission of Lippincott Williams & Wilkins. You may not alter or remove any trademark, copyright or other notice. However, provided that you maintain all copyright and other notices contained therein, you may download material (one machine readable copy and one print copy per page) for your personal, non-commercial use only.

http://www.aidsonline.com http://www.ovid.com